“Distribution of SALT scores by Therapeutic Tesponse in Patients with Severe Alopecia After 52 weeks of Baricitinib Therapy” (2023) SKIN The Journal of Cutaneous Medicine, 7(6), p. s277. doi:10.25251/skin.7.supp.277.